Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:2388-2394
doi: 10.1161/CIRCULATIONAHA.107.740977
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, M. S.
Right arrow Articles by Carroll, J. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kim, M. S.
Right arrow Articles by Carroll, J. D.
Related Collections
Right arrow Cardiovascular imaging agents/Techniques
Right arrow Other etiology

(Circulation. 2008;117:2388-2394.)
© 2008 American Heart Association, Inc.


New Drugs and Technologies

Rapid Prototyping

A New Tool in Understanding and Treating Structural Heart Disease

Michael S. Kim, MD; Adam R. Hansgen, BS; Onno Wink, PhD; Robert A. Quaife, MD; John D. Carroll, MD

From the University of Colorado at Denver, Aurora, Colo (M.S.K., A.R.H., R.A.Q., J.D.C.); and Philips Healthcare, Bothell, Wash (O.W.).

Reprint requests to John D. Carroll, MD, University of Colorado at Denver, 12401 E 17th Ave, Room 524, Campus Mail Stop B-132, PO Box 6511, Aurora, CO 80045. E-mail John.Carroll{at}UCHSC.edu

As the appreciation of structural heart disease in children and adults has increased and as catheter-based closure procedures are now being performed in clinical practice, cardiovascular physicians have multiple compelling new reasons to better understand cardiac anatomic and spatial relationships. Current 2-dimensional imaging techniques remain limited both in their ability to represent the complex 3-dimensional relationships present in structural heart disease and in their capacity to adequately facilitate often complex corrective procedures. This review discusses the cardiovascular applications of rapid prototyping, a new technology that may not only play a significant role in the planning of catheter-based interventions but also may serve as a valuable educational tool to enhance the medical community’s understanding of the many forms of structural heart disease.


Key Words: computed tomography • heart defects, congenital • heart septal defects • percutaneous closure • rapid prototyping




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. Riesenkampff, U. Rietdorf, I. Wolf, B. Schnackenburg, P. Ewert, M. Huebler, V. Alexi-Meskishvili, R. H. Anderson, N. Engel, H.-P. Meinzer, et al.
The practical clinical value of three-dimensional models of complex congenitally malformed hearts
J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 571 - 580.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
M. S. Kim, I. P. Casserly, J. A. Garcia, A. J. Klein, E. E. Salcedo, and J. D. Carroll
Percutaneous Transcatheter Closure of Prosthetic Mitral Paravalvular Leaks: Are We There Yet?
J. Am. Coll. Cardiol. Intv., February 1, 2009; 2(2): 81 - 90.
[Abstract] [Full Text] [PDF]